ERBB3 and breast cancer: lncRNA BCAR4, identified in the ZR-75-1 BC cell screen, acts as an ERBB2/ERBB3 signaling driver oncogene and promotes estrogen-independent growth and anti-estrogen resistance in BC cells (20).